SNY - Amicus: July 29 PDUFA Makes It A Hold April, 11 2022 05:04 PM Sanofi Although AT-GAA failed a phase 3 trial, there are reasons it could be approved. Galafold continues to do very well. I will hold until the July 29 PDUFA. For further details see: Amicus: July 29 PDUFA Makes It A Hold